ClinicalTrials.Veeva

Menu

First Report, Five Years Experience of the Acute Leukemia Work Group (PR-GTLA)

M

Mexican Agrupation for Hematology Study

Status

Unknown

Conditions

Acute Leukemia (Category)

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02990104
2016001/PR-GTLA

Details and patient eligibility

About

The purpose of this study is to describe the incidence, clinic characteristics, biological and suvirval in Lymphoblastic Leukemia patients in Mexico City reference hospitals.

Full description

Multicenter and retrospective revision of clinical files with Acute Lymphoblastic Leukemia diagnostic between 2009 and 2013 in Mexico City reference hospitals, in five hospitals with 50 and 100 new cases Acute Lymphoblastic Leukemia per year. With a expected sample between 500 and 1000 patients it will descriptive statistics of variables. The data collection with necessary variables for survival analysis study and risk factors with Kaplan-Meier curve and risk proportional method Cox.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Clinical diagnosis of Acute Lymphoblastic Leukemia

Exclusion Criteria none

Trial contacts and locations

1

Loading...

Central trial contact

Dra. Roberta Demichelis, Doctor; Dra. Karla Espinoza, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems